Find a Tender
complete
Official procurement procedure
NHS National Generics Pharmaceuticals - Supply Chain Resilience
No classification published
Location not published
Published value
£52,447,296
Submission deadline 6 Mar 2026, 13:00 GMT
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Generics Pharmaceuticals - Supply Chain Resilience". Published status: complete. Published value: £52,447,296. 2 published lots. Recorded submission deadline: 6 Mar 2026, 13:00 GMT. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | Closed 6 Mar 2026, 13:00 GMT |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £52,447,296 |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
22.8Bids / Report
Supplier ConcentrationModerate Concentration
Anna FreudTop vendor: 29.6% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 859 active published awards; 13 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| Anna Freud | 1 win | £5,862,540 |
| Anglia Ruskin University | 1 win | £4,809,159 |
| NHS Shared Business Services Limited | 1 win | £4,393,727 |
| Pearson Professional Assessments Limited | 1 win | £4,374,320 |
| Timewise Foundation CIC | 1 win | £166,667 |
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published6 Jul 2026, 16:34 BST | Last source update6 Jul 2026, 16:34 BST | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-060abf | ||
What is being bought
NHS National Generics Pharmaceuticals - Supply Chain Resilience
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
Periods of call-offs under the framework agreement:
CM/PHG/25/5739/01 – Orals (plus non-parenteral) Products
CESW: (Midlands and Southwest): 1st September 2026 to 31st May 2028 (21 months)
NWLN: (Northwest and London North): 1st September 2026 to 31st May 2028 (21 months)
LSNE: (London South and Northeast): 1st September 2026 to 31st May 2028 (21 months)
CM/PHG/25/5739/02 – Hospital Only Products
DLS (London South) & DNE (North-East): 1st September 2026 to 31st May 2028 (21 months)
DLN (London North) & DNW (North-West): 1st September 2026 to 31st May 2028 (21 months)
DCE (Central/Midlands) & DSW (South-West): 1st September 2026 to 30th September 2027 (13 months)
This tender is for lines that have recently been terminated or unable to be awarded on previous tenders. Please note we have previously referred to these as “Housekeeping” tenders.
What changed
From the official release history
- Official notice release published
6 Jul 2026, 16:34 BST - tender value changed
1 May 2026, 14:38 BST - Status changed to complete
1 May 2026, 14:38 BST - Official notice release published
1 May 2026, 14:38 BST - Submission deadline changed to published date
1 May 2026, 14:38 BST - Official notice release published
26 Feb 2026, 15:25 GMT - Submission deadline changed to 6 Mar 2026, 13:00 GMT
26 Feb 2026, 15:25 GMT - Official notice release published
30 Jan 2026, 11:36 GMT - Status changed to active
30 Jan 2026, 10:15 GMT - Official notice release published
30 Jan 2026, 10:15 GMT - Submission deadline changed to 2 Mar 2026, 13:00 GMT
30 Jan 2026, 10:15 GMT - Published value updated to £52,447,296
21 Jan 2026, 10:56 GMT - Status changed to planning
21 Jan 2026, 10:56 GMT - Official notice release published
21 Jan 2026, 10:56 GMT - Buyer information updated
21 Jan 2026, 10:56 GMT
Lots and requirements (2)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
6 Jul 2026, 16:34 BST - Submission deadline
6 Mar 2026, 13:00 GMT - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 19 May 2026, 00:00 BST · £4,213,176 - Contract active
Signed 19 May 2026, 00:00 BST · £35,010,320
Commercial outcome and competition
Awards ASPIRE PHARMA LIMITED, Amarox Limited, CIPLA (EU) LIMITED, COLONIS PHARMA LIMITED, CRESCENT PHARMA LIMITED, DAY LEWIS MEDICAL LIMITED, ENNOGEN HEALTHCARE INTERNATIONAL LIMITED, G.L. Pharma UK Limited, MILPHARM LIMITED, MORNINGSIDE PHARMACEUTICALS LIMITED, Northumbria Pharma Limited, SELECTIVE SUPPLIES LIMITED, TEVA UK LIMITED, WOCKHARDT UK LIMITED Not published · Not published · active ASCEND LABORATORIES (UK) LIMITED, ASPIRE PHARMA LIMITED, Amarox Limited, BAXTER HEALTHCARE LIMITED, BROWN & BURK UK LIMITED, CIPLA (EU) LIMITED, FRESENIUS KABI LIMITED, HIKMA PHARMACEUTICALS INTERNATIONAL LIMITED, JANSSEN-CILAG LIMITED, MACARTHYS LABORATORIES LIMITED, MILPHARM LIMITED, SUN PHARMA UK LIMITED, TEVA UK LIMITED, VIATRIS UK HEALTHCARE LIMITED, WOCKHARDT UK LIMITED Not published · Not published · active |
Contracts NHS National Generics Pharmaceuticals - Supply Chain Resilience Lot 1 Orals Products £4,213,176 · signed 19 May 2026, 00:00 BST · active Contract period: 1 Sept 2026, 00:00 BST — 31 May 2028, 23:59 BST NHS National Generics Pharmaceuticals - Supply Chain Resilience Lot 2 Hospital Only products £35,010,320 · signed 19 May 2026, 00:00 BST · active Contract period: 1 Sept 2026, 00:00 BST — 31 May 2028, 23:59 BST |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-PPON-PDPT-3135-BWWYDocuments (1)
Official links; attachments are not copied
Related procedures (0)
No related procedures published